| Net Cash Provided by (Used in) Operating Activities |
$192,900,000 |
USD |
27% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$73,400,000 |
USD |
-18% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$119,800,000 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
32,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
23,896,962 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
4 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$300,000 |
USD |
-111% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$700,000 |
USD |
-53% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$4,700,000 |
USD |
-42% |
Q1 2025 |
Q1 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$130,700,000 |
USD |
13% |
Q4 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$124,600,000 |
USD |
43% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$268,000,000 |
USD |
12% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$92,900,000 |
USD |
14% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
100 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |